Safety and efficacy of platelet-rich plasma in treatment of carpal tunnel syndrome; a randomized controlled trial

Table 6 The comparison of score changes in the two control and treatment groups

Variables	Group	Number	Mean	SD	P Value (Univariate)	Power	P Value (Multivariate-adjusted for age)
VAS change	Control	20	−2.90	2.1	0.845	0.073	0.398
VAS change	Treat	21	−2.76	2.4	0.845	0.073	0.398
Median SNAP PL change	Control	20	−0.15	0.2	0.820	0.091	0.858
Median SNAP PL change	Treat	20	−0.17	0.2	0.820	0.091	0.858
Median CMAP OL change	Control	20	−0.09	0.1	0.410	0.253	0.198
Median CMAP OL change	Treat	20	−0.04	0.2	0.410	0.253	0.198
Symptom severity scale change	Control	20	−0.70	0.3	0.922	0.063	0.629
Symptom severity scale change	Treat	19	−0.72	0.7	0.922	0.063	0.629
Functional scale change	Control	20	−0.86	0.5	0.289	0.283	0.554
Functional scale change	Treat	19	−0.63	0.8	0.289	0.283	0.554
Severity change	Control	20	−0.05	0.2	0.174	0.393	0.194
Severity change	Treat	21	−0.19	0.4	0.174	0.393	0.194

ISSN: 1471-2474